Name | Number of supported studies | Average coverage | |
---|---|---|---|
brush cell | 3 studies | 30% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 33% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 289.58 | 170 / 170 | 100% | 3.04 | 459 / 459 |
breast | 100% | 287.37 | 459 / 459 | 100% | 4.69 | 1117 / 1118 |
prostate | 100% | 352.17 | 245 / 245 | 100% | 3.13 | 501 / 502 |
ovary | 100% | 258.72 | 180 / 180 | 100% | 2.96 | 429 / 430 |
brain | 100% | 256.78 | 2637 / 2642 | 100% | 2.64 | 703 / 705 |
esophagus | 100% | 223.65 | 1445 / 1445 | 99% | 3.68 | 182 / 183 |
lung | 100% | 228.25 | 576 / 578 | 99% | 2.81 | 1144 / 1155 |
bladder | 100% | 250.76 | 21 / 21 | 99% | 2.65 | 497 / 504 |
liver | 100% | 284.75 | 226 / 226 | 99% | 2.78 | 400 / 406 |
intestine | 100% | 242.04 | 966 / 966 | 98% | 2.33 | 516 / 527 |
stomach | 100% | 276.47 | 359 / 359 | 98% | 2.67 | 280 / 286 |
pancreas | 100% | 243.50 | 328 / 328 | 98% | 2.22 | 174 / 178 |
skin | 100% | 348.74 | 1809 / 1809 | 97% | 2.77 | 460 / 472 |
thymus | 100% | 239.55 | 653 / 653 | 94% | 1.75 | 570 / 605 |
adrenal gland | 100% | 348.60 | 258 / 258 | 93% | 1.99 | 214 / 230 |
kidney | 100% | 330.12 | 89 / 89 | 92% | 2.04 | 826 / 901 |
adipose | 100% | 241.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 306.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 1.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.74 | 1 / 1 |
muscle | 100% | 160.48 | 801 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 177.98 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 161.82 | 846 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 2.16 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 88% | 1.80 | 70 / 80 |
peripheral blood | 76% | 118.89 | 703 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030217 | Biological process | T cell differentiation |
GO_0015031 | Biological process | protein transport |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0098656 | Biological process | monoatomic anion transmembrane transport |
GO_0051452 | Biological process | intracellular pH reduction |
GO_0034702 | Cellular component | monoatomic ion channel complex |
GO_0030660 | Cellular component | Golgi-associated vesicle membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0008308 | Molecular function | voltage-gated monoatomic anion channel activity |
Gene name | GPR89A |
Protein name | G protein-coupled receptor 89A G protein-coupled receptor 89A isoform B G protein-coupled receptor 89A isoform D Golgi pH regulator A (Protein GPR89A) (Putative MAPK-activating protein PM01) (Putative NF-kappa-B-activating protein 90) |
Synonyms | CGI-13 UNQ192/PRO218 GPHRA SH120 GPR89 |
Description | FUNCTION: Voltage dependent anion channel required for acidification and functions of the Golgi apparatus that may function in counter-ion conductance . Plays a role in lymphocyte development, probably by acting as a RABL3 effector in hematopoietic cells (By similarity). . |
Accessions | E9PRZ5 ENST00000460277.5 [B7ZAQ6-4] ENST00000534502.5 [B7ZAQ6-3] ENST00000462900.2 [B7ZAQ6-3] X5D9J6 B7ZAQ6 ENST00000524525.5 E9PKY3 ENST00000466593.5 ENST00000528944.5 [B7ZAQ6-4] ENST00000313835.14 [B7ZAQ6-1] X5D920 |